Giugliani & Poswar (UpToDate) - Management of neurological manifestations.
PCDT, 2025 - Brazilian public health system guidelines for diagnosis and treatment of Fabry disease (agalsidase alfa and agalsidase beta)
Stepien et al., 2023 - UK consensus
Burlina et al., 2023 - Biomarkers for Fabry Disease
Généo, 2021 - Treatment protocol of the French Fabry Disease Reference Center.
Germain et al., 2019 - Expert consensus on management of children
Wanner et al., 2018 - European consensus on therapeutic goals
Ortiz et al., 2018 - Expert consensus on management of adult patients
Sirrs et al., 2018 - Canadian Protocol